EHDN Elections 2026:
Introducing the New Executive Committee Members
Highlight from the: EHDN Newsletter_November2026_Issue59
Biennial elections for the EHDN Executive Committee and Scientific and Bioethics Advisory Committee ran from 1 June to 19 October 2026, in accordance with the EHDN Constitution.
The Executive Committee governs EHDN, directs and oversees its activities, and sets the Network’s strategic direction, as outlined in Article 4 of the EHDN Constitution. In 2026, four positions were filled, with votes cast for individual candidates. Voter turnout was encourag ingly higher than in recent years, and we look forward to building on this further in future voting cycles.
At EHDN CRC 2026, Executive Chair Patrick Weydt thanked the EHDN membership for voting and announced that Åsa Petersén and Ed Wild were re-elected, and that Mayke Oosterloo and Chiara Zuccato would be joining the Executive Committee as newly appointed members. Here, in their own words, Mayke and Chiara reflect on what these appointments mean to them.
![]() |
Mayke Oosterloo Assistant Professor |
“I am a neurologist specialising in Huntington’s disease at Maastricht University Medical Centre in the Netherlands, where I lead the Huntington’s Disease Expertise Centre. I have been actively involved in the EHDN for several years, including as a member of the Scientific and Bioethics Advisory Committee.
I am honoured to join the Executive Committee and sincerely thank everyone who placed their trust in me. I hope to bring my clinical and research experience, strengthen collaboration between researchers, health care professionals and patients, and contribute to translating scientific advances into meaningful improvements in care for Huntington’s disease families.”
![]() |
Chiara Zuccato Associate Professor of Pharmacology |
“I am a basic scientist at the University of Milan. My research focuses on identifying the determinants of synaptic dysfunction to develop new strategies against cognitive decline in HD. Throughout my career, I have actively engaged with patient associations, fostering dialogue among researchers, clinicians, and HD families.
After four years on the EHDN Scientific and Bioethics Advisory Committee, joining the Executive Committee is a privilege. I am deeply grateful for this opportunity.
I believe that research can only make a real difference if it walks hand in hand with patients. I will leverage my expertise to create the ‘HD Young Scientists Network’, connecting young researchers working on HD in Europe, and promote a dedicated EHDN conference session in which the young scientists and families can meet.”




